Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$50,208,000
+$15,408,844 QoQ
Shares Held
2,400,000
-38.9% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bellevue Group AG holds $2,583,944,637 across 59 Biotechnology names. TNGX ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
681,908 | $304,499,197 | |
| 2 | ARGX |
Argenx SE
|
313,000 | $228,568,250 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
278,674 | $215,314,678 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
3,584,573 | $176,217,608 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,544,456 | $150,198,346 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
1,818,665 | $136,563,554 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,726,144 | $131,563,376 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
481,785 | $124,454,701 |
All Filings in TNGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,208,000 | 2,400,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,799,156 | 3,927,670 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||